Sleep 2013
SLEEP 2013, the 27th Annual Meeting of the Associated Professional Sleep Societies, LLC (APSS) will be held June 1-5, 2013, at the Baltimore Convention Center. SLEEP is the only five-day meeting in the nation with scientific sessions and an exhibition hall focused solely on sleep medicine and sleep research.
Day 1
The NIH: Opportunities in the Digital Age
In his presentation, Gary H. Gibbons, MD, director of the National Heart, Lung, and Blood Institute at the National Institutes of Health, described the functions of his organization and discussed the potential for improvements in the understanding of disease states in the digital age.
Dr Jennifer Martin Discusses How Insomnia Has Evolved & Affects In Insurance Coverage
In this video, Jennifer Martin, PhD, Assistant Professor, UCLA, David School of Medicine, shares her thoughts on how non-pharmacologic treatments for the management of insomnia has evolved over the past few years and how the increased use of behavioral treatments might affect insurance coverage.
Epilepsy and Sleep: Defining the Relationship
Sleep disorders are common in patients with epilepsy; approximately 70% of patients with epilepsy experience problems with sleep. In his presentation, Dr Erik St. Louis discussed the impact of sleep on seizures, as well as the effects of comorbid sleep disorders on epilepsy.
Dr Thomas Roth Gives His Opinion About The Most Important Advance in Insomnia Pathology
In this video, Thomas Roth, PhD, Professor, Department of Psychiatry, Wayne State University School of Medicine, provides his opinion on the most important advance in our understanding of insomnia pathology in recent years.
Day 2
Sleep Studies in Patients With Epilepsy
The electroencephalogram (EEG) provides important information to aid clinicians in the diagnosis of epilepsy. However, EEG techniques are associated with certain limitations, as discussed in the presentation by Bradley V. Vaughn, MD.
Dr Zee Discusses the Relationship Between Circadian Disruption and Metabolic Disease
In this video, Phyllis Zee, MD, Associate Director, Center for Sleep & Circadian Biology, discusses the relationship between circadian disruption and metabolic disease.
Sleepiness in a 24/7 World with Dr. Hans Van Dongen, PhD
In this presentation, Dr. Van Dongen discussed the pharmacology of various treatments for sleep disturbance associated with shift work. Dr. Van Dongen discussed the issues associated with use of medications to improve the alertness of sleepy workers.
Dr Jennifer Martin Talks About the Effectiveness of Cognitive Behavioral Treatment for Insomnia
In this video, Jennifer Martin, PhD, Assistant Professor, UCLA, David School of Medicine, discusses how the effectiveness of cognitive behavioral treatment for insomnia among patients with dementia compare with current pharmacologic strategies.
Day 3
Sleep and Sleep Disorders: Comorbid Conditions and Pathophysiology
Dr Thomas Roth, PhD, presented on the evolution of our understanding of insomnia, and the importance of insomnia in the context of other disease states. Roth noted that insomnia is primarily a disorder of increased wakefulness from a pathophysiologic standpoint, and presented data to support this. Presenting the effect of improved sleep on diseases such as depression, worker productivity, and cardiovascular disease, Roth revealed rich prospects for the future of sleep medicine in treating a variety of disorders.
Dr Horne Provides His Opinion on the Relationship Between Lack of Sleep and Obesity
In this video, James Horne, PhD, Director, Sleep Research Centre, provides his opinion on the relationship between lack of sleep and obesity.
The Neurobiology of Sleep Loss in Humans
In a session on the neurobiology of sleep loss in humans, Andrea Spaeth, Daniel Aeschbach, PhD, and Clare Anderson, PhD, presented findings about the effects of sleep deprivation on various biological measures in humans.
Dr Sharon Discusses How Insurers Have Responded to the Availability of Therapies for RLS
In this video, Denise Sharon, MD, PhD, Clinical Director and Founding Partner, Comprehensive Sleep Medicine Center of the Gulf Coast, discusses how insurers have responded to the availability of therapies and changes in clinical practice guidelines for RLS.
Managing Restless Leg Syndrome: Current Strategies and Treatment Guidelines
In this session, Stephany Fulda, PhD, discussed the common causes of restless leg syndrome (RLS), considerations for the clinical application of treatment strategies for RLS, and changes to treatment guidelines for RLS that may be on the horizon.
Restless Legs Syndrome/Willis-Ekbom Disease Diagnostic Criteria: Why Change?
In this session, Daniel Picchietti, MD, discussed changes to the diagnostic guidelines for restless legs syndrome/Willis-Ekbom disease published jointly by the International Restless Legs Syndrome Study Group and the National Institutes of Health.